Comparable stake leader
T. Rowe Price Investment Management, Inc.
SEC ownership of PROCEPT BioRobotics Corp
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001588978.
Disclosed value leader
CPMG Inc
Comparable rows
50/50
Latest evidence
16 Apr 2026
- Public ticker
- PRCT on Nasdaq
- Parsed ownership sources
- 13D/G, 13F, and 3/4/5
- Largest SEC-reported holder
- T. Rowe Price Investment Management, Inc.
- Latest 13D/G holder
- T. Rowe Price Investment Management, Inc.
- Latest parsed ownership date
- 16 Apr 2026
- Issuer CIK
- 0001588978
- Issuer location
- San Jose, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of PROCEPT BioRobotics Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
T. Rowe Price Investment ...
Disclosed value leader
CPMG Inc
Comparable rows
50/50
Latest evidence
16 Apr 2026
13D/G
13F
3/4/5
Lead comparable stake: 5.9%
13D/G row: T. Rowe Price Investment Management, Inc.
Showing 1-8 of 50 holder rows.
Quick read
T. Rowe Price Investment Management, Inc. leads the comparable SEC ownership view at 5.9%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens T. Rowe Price Investment Management, Inc.'s linked filing trail.
Comparable ownership
Top 5
T. Rowe Price Investment Manageme...
5.9%
BNP Paribas Asset Management Hold...
5.5%
VANGUARD CAPITAL MANAGEMENT LLC
5%
FMR LLC
2.9%
ALLIANCEBERNSTEIN L.P.
0.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. |
13D/G
13F
Company
|
5.9%
|
$100,039,657
3,271,408 shares
|
$0 | 31 Dec 2025 |
| BNP Paribas Asset Management Holding S.A. |
13D/G
13F
Company
|
5.5%
|
$94,634,366
3,094,649 shares
|
$0 | 31 Dec 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5%
|
$70,538,954
2,820,430 shares
|
$0 | 31 Mar 2026 |
| FMR LLC |
13D/G
13F
Company
|
2.9%
|
$45,888,947
1,610,138 shares
|
-$86,724,702 | 27 Feb 2026 |
| ALLIANCEBERNSTEIN L.P. |
13F
13D/G
Company
|
0.3%
from 13D/G
|
$4,634,907
147,327 shares
|
— | 31 Mar 2026 |
| Antal Rohit Desai |
3/4/5
Director
|
0.84%
|
$12,257,125
475,777 shares
mixed-class rows
|
+$5,763,451 | 05 Mar 2026 |
| Barry L. Templin |
3/4/5
EVP, Chief Technology Officer
|
0.22%
|
$3,145,457
125,768 shares
|
— | 16 Apr 2026 |
| Pooja Sharma |
3/4/5
Chief Strat/Marketing Officer
|
0.16%
|
$2,189,850
87,559 shares
|
— | 16 Apr 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$4,692,434.
Buys
$11,268,081
Insiders: 2
Sells
$6,575,647
Insiders: 4
Net
+$4,692,434
Shares: +328,033
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 446,262
Shares: 118,229
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 98,699 | 9,616 | $2,422,891 | $250,863 | +$2,172,028 |
| 3-6 | 327,563 | 13,613 | $8,060,052 | $322,654 | +$7,737,398 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 20,000 | 95,000 | $785,138 | $6,002,130 | -$5,216,992 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 20 reporting-owner rows connected to PROCEPT BioRobotics Corp. Open a relationship link for the CIK-to-CIK filing trail.
Rows
20
Largest Forms 3/4/5 holder
CPMG Inc
Net 12M change
+$5,975,072
Latest report
16 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| CPMG Inc | 10%+ Owner | $490,969,607 | Mixed | 17 Mar 2022 | ||
| R. Kent Jr. McGaughy | 10%+ Owner | $242,100,658 | Mixed | 03 May 2024 | ||
| Frederic H. Moll | Director | $33,884,946 | +$785,138 | +2.4% | Filing P/S | 13 Aug 2025 |
| VIKING GLOBAL INVESTORS LP | 10%+ Owner | $13,409,444 | Mixed | 18 Mar 2022 | ||
| Antal Rohit Desai | Director | $12,257,125 | +$5,763,451 | +89% | Mixed | 05 Mar 2026 |
| Larry L. Wood | President, CEO, Director | $8,942,792 | Mixed | 05 Mar 2026 | ||
| Taylor C. Harris | Director | $7,141,536 | Mixed | 10 Jun 2025 | ||
| Ph.D. Reza Zadno | President, CEO, Director | $5,741,081 | Mixed | 09 May 2025 | ||
| Morgan Colby Wood | Director | $5,077,621 | Mixed | 13 Nov 2023 | ||
| Hisham Shiblaq | EVP, Chief Comm. Officer | $4,670,471 | Mixed | 06 Jun 2025 | ||
| Kevin Waters | Evp, Cfo | $4,354,212 | -$179,177 | -4% | Mixed | 17 Mar 2026 |
| Barry L. Templin | EVP, Chief Technology Officer | $3,145,457 | Median | 16 Apr 2026 | ||
| Thomas M. Krummel | Director | $3,021,847 | Mixed | 04 Jun 2024 | ||
| Alaleh Nouri | Evp, Clo, Corp. Sec. | $2,873,574 | -$394,340 | -12% | Mixed | 19 Mar 2026 |
| Pooja Sharma | Chief Strat/Marketing Officer | $2,189,850 | Median | 16 Apr 2026 | ||
| Mary Garrett | Director | $775,506 | Mixed | 10 Jun 2025 | ||
| Elisabeth Sandoval Little | Director | $678,633 | Mixed | 10 Jun 2025 | ||
| Amy M. Dodrill | Director | $416,535 | Mixed | 10 Jun 2025 | ||
| Thomas M. Prescott | Director | $225,680 | Mixed | 10 Jun 2025 | ||
| Dan Puckett | Director | $156,066 | Mixed | 05 Mar 2026 |
Recent insider transactions for PROCEPT BioRobotics Corp
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Alaleh Nouri | PRCT | Common Stock | Sale | -4.84% | $139,231 | $25.96 | -5,363 | 105,354 | 19 Mar 2026 | Direct |
| Alaleh Nouri | PRCT | Common Stock | Sale | -0.27% | $8,559 | $28.15 | -304 | 110,717 | 17 Mar 2026 | Direct |
| Kevin Waters | PRCT | Common Stock | Sale | -0.46% | $19,876 | $28.15 | -706 | 151,558 | 17 Mar 2026 | Direct |
| Alaleh Nouri | PRCT | Common Stock | Sale | -2.84% | $83,197 | $25.65 | -3,243 | 111,021 | 10 Mar 2026 | Direct |
| Antal Rohit Desai | PRCT | Common Stock | Purchase | 30.1% | $2,422,891 | $24.55 | 98,699 | 426,262 | 09 Mar 2026 | Kestrel Fund, L.P. |
| Antal Rohit Desai | PRCT | Common Stock | Purchase | 95.9% | $3,781,503 | $23.59 | 160,317 | 327,563 | 06 Mar 2026 | Kestrel Fund, L.P. |
| Alaleh Nouri | PRCT | Common Stock | Sale | -5.69% | $163,353 | $23.70 | -6,892 | 114,264 | 06 Mar 2026 | Direct |
| Kevin Waters | PRCT | Common Stock | Sale | -4.23% | $159,300 | $23.70 | -6,721 | 152,264 | 06 Mar 2026 | Direct |
| Antal Rohit Desai | PRCT | Common Stock | Purchase | $4,278,549 | $25.58 | 167,246 | 167,246 | 05 Mar 2026 | Kestrel Fund, L.P. | |
| Larry L. Wood | PRCT | Common Stock | Award | 68.8% | 127,783 | 313,378 | 05 Mar 2026 | Direct | ||
| Larry L. Wood | PRCT | Stock Option (Right to Buy) | Award | 103,653 | 103,653 | 05 Mar 2026 | Direct | |||
| Alaleh Nouri | PRCT | Common Stock | Award | 56.6% | 43,811 | 121,156 | 05 Mar 2026 | Direct | ||
| Alaleh Nouri | PRCT | Stock Option (Right to Buy) | Award | 29,615 | 29,615 | 05 Mar 2026 | Direct | |||
| Kevin Waters | PRCT | Common Stock | Award | 42.6% | 47,462 | 158,985 | 05 Mar 2026 | Direct | ||
| Kevin Waters | PRCT | Stock Option (Right to Buy) | Award | 32,576 | 32,576 | 05 Mar 2026 | Direct | |||
| Dan Puckett | PRCT | Common Stock | Award | 5,476 | 5,476 | 05 Mar 2026 | Direct | |||
| Dan Puckett | PRCT | Stock Option (Right to Buy) | Award | 8,897 | 8,897 | 05 Mar 2026 | Direct | |||
| Alaleh Nouri | PRCT | Common Stock | Award | 6.72% | 4,872 | 77,345 | 19 Feb 2026 | Direct | ||
| Kevin Waters | PRCT | Common Stock | Award | 3.27% | 3,532 | 111,523 | 19 Feb 2026 | Direct | ||
| Larry L. Wood | PRCT | Common Stock | Award | 5694.4% | 182,392 | 185,595 | 02 Sep 2025 | Direct | ||
| Larry L. Wood | PRCT | Stock Option (Right to Buy) | Award | 319,618 | 319,618 | 02 Sep 2025 | Direct | |||
| Mr. Antal Rohit Desai | PRCT | Common Stock | Options Exercise | 318.3% | 26,749 | 35,152 | 14 Aug 2025 | Direct | ||
| Mr. Antal Rohit Desai | PRCT | Stock Option (Right to Buy) | Options Exercise | -100% | -26,749 | 0 | 14 Aug 2025 | Direct | ||
| Alaleh Nouri | PRCT | Common Stock | Options Exercise | 17.9% | 11,000 | 72,473 | 14 Aug 2025 | Direct | ||
| Alaleh Nouri | PRCT | Stock Option (Right to Buy) | Options Exercise | -16.8% | -11,000 | 54,452 | 14 Aug 2025 | Direct | ||
| Frederic H. Moll | PRCT | Common Stock | Purchase | 2.37% | $785,138 | $39.26 | 20,000 | 863,159 | 13 Aug 2025 | Direct |
| Mr. Antal Rohit Desai | PRCT | Common Stock | Sale | -63.5% | $1,537,256 | $61.49 | -25,000 | 14,363 | 12 Jun 2025 | By The 2:22 DNA Trust |
| Mr. Antal Rohit Desai | PRCT | Common Stock | Sale | -38.8% | $1,584,525 | $63.38 | -25,000 | 39,363 | 11 Jun 2025 | By The 2:22 DNA Trust |
| Mr. Antal Rohit Desai | PRCT | Common Stock | Award | 22.4% | 1,538 | 8,403 | 10 Jun 2025 | Direct | ||
| Mr. Antal Rohit Desai | PRCT | Common Stock | Sale | -28% | $1,597,711 | $63.91 | -25,000 | 64,363 | 10 Jun 2025 | By The 2:22 DNA Trust |
| Mr. Antal Rohit Desai | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Frederic H. Moll | PRCT | Common Stock | Award | 0.18% | 1,538 | 843,159 | 10 Jun 2025 | Direct | ||
| Frederic H. Moll | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Elisabeth Sandoval | PRCT | Common Stock | Award | 14% | 1,538 | 12,561 | 10 Jun 2025 | Direct | ||
| Elisabeth Sandoval | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Larry L. Wood | PRCT | Common Stock | Award | 34.7% | 1,538 | 5,968 | 10 Jun 2025 | Direct | ||
| Larry L. Wood | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Taylor C. Harris | PRCT | Common Stock | Award | 1.58% | 1,538 | 99,176 | 10 Jun 2025 | Direct | ||
| Taylor C. Harris | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Mary Garrett | PRCT | Common Stock | Award | 12% | 1,538 | 14,385 | 10 Jun 2025 | Direct | ||
| Mary Garrett | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Amy M. Dodrill | PRCT | Common Stock | Award | 25.3% | 1,538 | 7,626 | 10 Jun 2025 | Direct | ||
| Amy M. Dodrill | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Thomas M. Prescott | PRCT | Common Stock | Award | 65.2% | 1,538 | 3,896 | 10 Jun 2025 | Direct | ||
| Thomas M. Prescott | PRCT | Stock Option (Right to Buy) | Award | 2,771 | 2,771 | 10 Jun 2025 | Direct | |||
| Hisham Shiblaq | PRCT | Common Stock | Sale | -24.1% | $1,282,637 | $64.13 | -20,000 | 63,133 | 06 Jun 2025 | Direct |
| Hisham Shiblaq | PRCT | Common Stock | Options Exercise | 31.7% | 20,000 | 83,133 | 06 Jun 2025 | Direct | ||
| Hisham Shiblaq | PRCT | Stock Option (Right to Buy) | Options Exercise | -63.3% | -20,000 | 11,578 | 06 Jun 2025 | Direct |
* marks a reported price that did not pass the local price check.